Preferred Label : Davesomeran;
NCIt synonyms : CX-034476 OMICRON BA.4/BA.5;
NCIt definition : A formulation consisting of a lipid nanoparticle (LNP) encapsulating a messenger RNA
(mRNA) encoding the full-length, prefusion stabilized spike (S) protein of the severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Omicron variant lineages BA.4
and BA.5 (Omicron BA.4/BA.5), with potential immunizing activity against SARS-CoV-2.
Upon administration of davesomeran, the LNP binds to the plasma membrane of cells
and releases the mRNA into the cells. The mRNA is then translated by ribosomes to
produce the SARS-CoV-2 S protein. This may activate both humoral and cellular immune
responses which may result in protection against SARS-CoV-2 infection.;
UNII : TYF7YW7ENF;
CAS number : 2798905-80-1; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 2798905-80-1
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;
NCI Metathesaurus CUI : CL1799335;
Origin ID : C190750;
UMLS CUI : C5709280;
Semantic type(s)
- concept_is_in_subset
https://www.has-sante.fr/jcms/p_3466353/fr/spikevax-elasomeran-/-davesomeran-/-andusomeran-covid-19
2023
false
false
false
France
COVID-19 Vaccines
mRNA Vaccines
insurance, health, reimbursement
first vaccination
Administration of vaccine product containing only severe acute respiratory syndrome
coronavirus 2 antigen (procedure)
covid-19, RNA-based vaccine
adult
vaccination
immunization, secondary
evaluation of the transparency committee
COVID-19
Elasomeran
Elasomeran
Davesomeran
---
https://www.has-sante.fr/jcms/p_3466353/fr/spikevax-elasomeran/davesomeran/andusomeran-covid-19
2023
false
false
false
France
vaccination
COVID-19 Vaccines
insurance, health, reimbursement
SARS-CoV-2 mRNA vaccine
drug combinations
immunization, secondary
first vaccination
Davesomeran
Elasomeran
Elasomeran/Davesomeran
evaluation of the transparency committee
COVID-19
---
